MedTrace Logo

Evaluation of Ocular Comfort With ISTA Tears vs Systane

NCT01650584 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2024-10-08

Study results available
· View outcomes & findings →

Summary

To assess the comfort preference of ISTA Tears vs Systane in patients with dry eye disease (DED)

Conditions

Interventions

DRUG

ISTA Tears

sterile ophthalmic solution

DRUG

Systane

Sterile ophthalmic solution

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    lead INDUSTRY

Principal Investigators

  • Tim McNamara, PharmD · ISTA Pharmaceuticals, Inc.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2012-12-31
Completion
2013-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01650584 on ClinicalTrials.gov